Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy-Reference-Cited by-同舟云学术

Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy

Published:2018-03-27 Issue:5 Volume:34 Page:903-910
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Kassem Loay¹,Shohdy Kyrillus S.¹,Abdel-Rahman Omar²

Affiliation:

1. Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt;

2. Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1447450

Reference36 articles.

1. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

2. Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

4. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Treatment for Metastatic Hormone-Sensitive Prostate Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses;Cancers;2023-12-06

2. Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer;Medical Decision Making;2023-10

3. Duplicated network meta-analysis in advanced prostate cancer: a case study and recommendations for change;Systematic Reviews;2022-12-16

4. Increasing the efficacy of abiraterone - from pharmacokinetics, through therapeutic drug monitoring to overcoming food effects with innovative pharmaceutical products;European Journal of Pharmaceutical Sciences;2022-09

5. Advancements in the treatment of metastatic hormone-sensitive prostate cancer;Frontiers in Oncology;2022-08-18